Katie J.L. Scott is a Silicon Valley-based associate in Dickstein Shapiro's Intellectual Property Practice. She focuses on IP and technology litigation, with an emphasis on patent matters. Ms. Scott has been actively involved in various stages of patent litigation, including prefiling investigation, fact development, discovery management, claim construction, infringement analysis, witness preparation, pre-trial coordination, post-trial motions, and appellate briefing. She also has experience with false advertising, business tort, unfair competition, and antitrust issues.
In 2007, Ms. Scott was part of the trial team that successfully asserted Amgen's EPO patent portfolio against Roche's MIRCERA product. In 2008, she was part of a trial team that defended Symantec Corporation in a patent infringement suit in the District of Delaware.
